Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yong-Fang Wei"'
Autor:
Hong‑Li Wu, Miao-Yu Guo, Xiao-Jian Han, Sheng-Lan Shi, Yu-Ying Wan, Li-Ping Jiang, Yong-Fang Wei
Publikováno v:
Oncology Reports. 38:985-992
Leukemia is a type of hematopoietic stem cell malignant cloned disease with high mortality. Cisplatin-based chemotherapy is one of the most common treatments for leukemia. Similar to other chemotherapeutic agents, cisplatin resistance has become a se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79acfab8114b8c0b12153e43ba826f8e
https://doi.org/10.3892/or.2017.5765
https://doi.org/10.3892/or.2017.5765
Autor:
Yu-Ying Wan, Qi-Nan Lai, Xiao-Jian Han, Li-Ping Jiang, Hongbo Xin, Jian-Feng Zhang, Jian-Bin Wang, Zhang-Jian Yang, Yong‑Fang Wei
Publikováno v:
Oncology Reports. 32:619-626
Glioblastoma is one of the most aggressive brain tumors with high morbidity and mortality. Hypoxia is often the common characteristic of tumor microenvironment, and hypoxia-inducible factor-1α (HIF-1α) is an essential factor regulating the migrator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c2b0aa56e91347739dbd0c9ea5221ee
https://doi.org/10.3892/or.2014.3235
https://doi.org/10.3892/or.2014.3235
Autor:
Li-Ping Jiang, Jian-Bin Wang, Zhang-Jian Yang, Yisong Qian, Hongbo Xin, Xuan Huang, Xiao-Jian Han, Yong-Fang Wei, Ming-Fang Liao, Yong Li, Yu-Ying Wan
Publikováno v:
International journal of oncology. 46(2)
Mitochondria are high dynamic organelles with frequent fission and fusion. Here, we found hypoxia stimulated Drp1 expression, mitochondrial fission and migration in metastatic MDA-MB‑231 cells, but not in non-metastatic MCF-7 cells. Inhibition of D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1033c044e1841e2201fd82b53408e0a
https://pubmed.ncbi.nlm.nih.gov/25434519
https://pubmed.ncbi.nlm.nih.gov/25434519
Publikováno v:
International Journal of Molecular Medicine
Liposomes as targeted drug delivery systems are an emerging strategy in the treatment of cancer to selectively target tumors or genes. In this study, we generated the recombinant protein, EC1-GLuc, by fusing the EC1 peptide, an artificial ligand of E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0408e60da093dc8fdcfbaf31511f43c1
https://pubmed.ncbi.nlm.nih.gov/25190023
https://pubmed.ncbi.nlm.nih.gov/25190023
Autor:
XIAO-JIAN HAN, SHENG-LAN SHI, YONG-FANG WEI, LI-PING JIANG, MIAO-YU GUO, HONG-LI WU, YU-YING WAN
Publikováno v:
Oncology Reports; Aug2017, Vol. 38 Issue 2, p985-992, 11p
Autor:
XIAO-JIA NHAN, ZHANG-JIA NYANG, LI-PING JIANG, YONG-FANG WEI, MING-FANG LIAO, YISO NGQIAN, YONG LI, XUAN HUANG, JIAN-BIN WANG, HONG-BO XIN, YU-YING WAN
Publikováno v:
International Journal of Oncology; 2015, Vol. 46 Issue 2, p691-700, 10p